Andere Sprachen TransMedics Group, Inc.

Aktien

A2PH5P

US89377M1099

TMDX

Realtime-Estimate Cboe BZX Andere Börsenplätze 17:05:34 30.04.2024			% 5 Tage	% 1. Jan.
94,88 ^USD	-2,44 %		+5,85 %	+21,50 %

18.04.	Insider der Transmedics Group verkaufte Aktien im Wert von $380.480, laut einer aktuellen SEC Einreichung	MT
05.04.	Insider der Transmedics Group verkaufte Aktien im Wert von $802.084, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing	18.04.
TransMedics to Report First Quarter 2024 Financial Results on April 30, 2024	16.04.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	08.04.
Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing	05.04.
Transmedics Group Insider Sold Shares Worth $1,110,150, According to a Recent SEC Filing	02.04.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	19.03.
TMDX INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation - TMDX	03.03.
TransMedics to Present at Upcoming March Investor Conferences	28.02.
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	28.02.
Top Premarket Gainers	27.02.
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages TransMedics Group, Inc. Investors to Inquire About Securities Class Action Investigation – TMDX	27.02.
TransMedics: Q4 Earnings Snapshot	26.02.
TransMedics Group Swings to Net Income in Q4, Revenue Increases; Sets 2024 Revenue Outlook-- Shares Rise	26.02.
TransMedics Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.02.
TransMedics Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	26.02.
TransMedics Reports Fourth Quarter and Full Year 2023 Financial Results	26.02.
Earnings Flash (TMDX) TRANSMEDICS GROUP Posts Q4 Revenue $81.2M, vs. Street Est of $68.5M	26.02.
Transmedics Group, Inc. Provides Revenue Guidance for the Full-Year 2024	26.02.
Transmedics Group Insider Sold Shares Worth $279,720, According to a Recent SEC Filing	21.02.
Transmedics Group Insider Sold Shares Worth $344,432, According to a Recent SEC Filing	16.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen TransMedics Group, Inc.

Aktien

A2PH5P

US89377M1099

TMDX

Andere Sprachen

Filter